The Society for Women’s Health Research and the Endocrine Society are briefing Congress this week on the importance of including more women and minorities in biomedical research.
Two groups with an interest in medical research are hoping to change the way biomedical studies are conducted.
This week the Society for Women’s Health Research and the Endocrine Society are cosponsoring a Congressional briefing to advocate for the need to include more females in clinical and preclinical studies.
“Although biomedical research drives scientific discovery and innovative medical treatments, it is well known that women and minorities remain underrepresented in most research studies,” the groups said in a statement. “To truly usher in medical treatments that are tailored to the patient, women and minorities must be reflected in the research studies used to approve new and novel medical treatments.”
According to the two groups, women have higher rates of adverse effects from approved medical products, which result in the products being pulled from the market. Federally funded medical research should be structured in a way that allows for the best return on investment, the groups added.
(Click here to read the full article written by Katie Bascuas, AssociationsNow.com)